Delivery Order SPE2DE24DA010-SPE2D625F8HE1
- Not listed
- This federal contract award is for the delivery of cardiovascular medical devices and related services to the Department of Veterans Affairs (VA) and Defense Health Agency. The prime contractor is Abbott Laboratories Inc., a large multinational pharmaceutical and medical device manufacturer, through its Abbott Vascular Inc. division. The contract has a ceiling value of $25,995.85 and an ultimate completion date of February 6, 2025. It is a fixed-price delivery order contract with economic...
- This federal contract award is for the delivery of cardiovascular medical devices and related services to the Department of Veterans Affairs (VA) and Defense Logistics Agency (DLA). The prime contractor is Abbott Laboratories Inc., through its Abbott Vascular Inc. division, a major global manufacturer of medical devices. The $2,373 fixed-price delivery order contract has an ultimate completion date of November 26, 2024. The contract does not have a set-aside designation, indicating full and open...
- This federal contract award to Abbott Laboratories Inc., a large pharmaceutical and medical device manufacturer, is for the delivery of a variety of cardiovascular medical devices and related services to support the Department of Veterans Affairs (VA) and Defense Health Agency. Specifically, the $1,120 fixed-price contract is for items such as stents, pacemakers, heart valves, and implantable cardiac monitors, as well as catheter labs, mapping systems, and inventory management. The award is a...
- This federal contract award, valued at $21,147.00, was issued by the Department of Defense's Medical Supply Chain agency to Abbott Laboratories Inc.'s Abbott Vascular Inc. division. The contract is a fixed-price delivery order with economic price adjustment, with a completion date of December 3, 2024. The award covers the provision of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants....
- This federal contract award, valued at $8,700.85, was made by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a major pharmaceutical and medical device manufacturer. The contract is a delivery order for the supply of cardiovascular medical devices, including stents, pacemakers, heart valves, and surgical implants, to support the Defense Health Agency and Department of Veterans Affairs (VA) healthcare systems. The contract is a firm fixed-price with economic price adjustment and...
- This federal contract award, valued at $6,846.00, was made by the Medical Supply Chain division of the Defense Logistics Agency to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract provides for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract is a firm fixed-price delivery order with economic price adjustment. No set-aside...
- This is a federal contract award to Abbott Laboratories Inc., a global healthcare company, for the supply of cardiovascular medical devices and related services. The contract, valued at $15,552.00, is a firm fixed-price purchase order with the Veterans Integrated Service Network 12, a civilian agency under the Department of Veterans Affairs (VA). The contract does not have a set-aside designation, indicating full and open competition. Abbott Laboratories, through its Abbott Vascular division, is...
- This is a federal contract award to Abbott Laboratories Inc., a large pharmaceutical and medical device manufacturer, by the Defense Logistics Agency (DLA) and Department of Veterans Affairs (VA). The contract has an award value of $25,715.85 and is a firm fixed-price delivery order with economic price adjustment. The contract covers the delivery of a variety of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and...
- This federal contract award is a $83,550.00 fixed-price delivery order issued by the Medical Supply Chain, an alternate name for the Defense agency, to Abbott Laboratories Inc., the prime contractor. The contract, which does not have a set-aside designation, covers the delivery of cardiovascular medical devices and related services to support federal healthcare systems, particularly the Department of Veterans Affairs (VA) and the Defense Logistics Agency (DLA). Abbott Laboratories Inc.,...
- This federal contract award, valued at $25,715.85, was issued by the Defense Logistics Agency's Medical Supply Chain to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The award is for the delivery of various cardiovascular medical devices and systems, including stents, pacemakers, heart valves, and implantable cardiac monitors, to support the healthcare needs of veterans at Department of Veterans Affairs (VA) hospitals and clinics nationwide. Abbott Vascular has been awarded...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D625F8HE1Delivery Order
This federal contract award is for a fixed-price delivery order with economic price adjustment, valued at $7,864.75, awarded by the Department of Veterans Affairs (VA) Medical Supply Chain to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is for the delivery of advanced cardiovascular medical technologies, including the EnSite X Mapping System, MitraClip, Aveir Leadless Pacemakers, and various prosthetic devices, to support complex medical procedures and improve patient outcomes across the VA healthcare system. Abbott Laboratories Inc. is a global healthcare company that has secured multiple Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) with the VA and the Defense Logistics Agency (DLA) for the provision of comprehensive medical products and services, particularly in the areas of cardiovascular devices, diagnostic solutions, and specialized medical equipment. This contract award, which does not have a set-aside designation, is part of the company's broader strategic role as a critical supplier of advanced medical technologies to federal healthcare agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 7/17/25 |